Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New vitamin supplements aim to make life easier for kids with rare metabolic disorders

NCT ID NCT07619170

Symptom relief Sponsor: NeoteriQ Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests new vitamin and mineral supplements called EasiVits for children aged 1-16 with inborn errors of metabolism (IEM). These supplements have less carbohydrate and no flavor, so they can be used with different diets and kids can add their own taste. The goal is to see if children find them more acceptable and easier to tolerate than current supplements. About 30 children will try EasiVits for 7 days, and researchers will track how well they take them and any stomach issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Mar 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 year to 16 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male and female IEM patients ages 1-16 years. * Patients diagnosed with an IEM. * Taking vitamin and mineral supplements for IEM and willing to take the new supplements for 7 days. * Absence of comorbidities. * Adherence with dietary management and vitamin and mineral supplements. * Able to understand and comply with the requirements of the investigation and sign the Informed Consent Form/Assent form. Exclusion Criteria: * Age \<1 years old. * Patients with comorbidities. * Any moderate to severe acute illness which in the opinion of the Investigator would interfere with the study procedures or study outcome. * History of poor co-operation, non-adherence with dietary management, or poor adherence to investigation procedures. * Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Inborn errors of metabolism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

inborn errors of metabolism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Inborn errors of metabolism

Contacts and locations

Locations

  • Birmingham Children's Hospital

    Birmingham, B4 6NH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.